Contract Pharmaceutical Fermentation Services Market Forecast, Trend Analysis & Competition Tracking - Global Review 2018 to 2028

  • Published : Ongoing
  • Category : ICT
  • Report Code : FACT1517MR

Traditionally, the fermentation process was defined as the conversion of sugar into carbon dioxide and alcohol by the anaerobic method with the help of yeast, but this definition has evolved with the passage of time due to the dynamic usage of this process in varying applications. One such evolved area of application of the fermentation process is the pharmaceutical industry where the process is employed for the preparation of various Active Pharmaceutical Ingredients (API). Traditionally, fermentation in the pharmaceutical industry was limited to various medically important products such as antibiotics, solvents, probiotics and citric acid and recent developments have paved way for the implementation of this process in products such as anti-viral drugs, therapeutic recombinant proteins, monoclonal antibodies and DNA. Various types of antibiotics are developed using fermentation technology; for example, antibacterial, antifungal, antiviral and anti-parasitic antibiotics, among others. Therefore, fermentation remains a key process in the rapidly growing biopharmaceutical industry.

Various pharmaceutical manufacturers are deriving medical products from fermented products with active pharmaceutical ingredients, which is creating a demand for contract pharmaceutical fermentation services for bulk supply. Contract pharmaceutical fermentation services provide bulk quantities of fermented biological products to different pharmaceutical companies for manufacturing purposes.

Contract pharmaceutical fermentation services are useful for pharmaceutical companies when large volumes of fermented products are required for the development of any drug formulation due to a sudden outbreak of any disease or surge in the instances of any condition. Contract pharmaceutical fermentation services offer different types of fermentation techniques with skilled personnel.

Contract Pharmaceutical Fermentation Services Market: Drivers and Restraints

Contract pharmaceutical fermentation services develop products used by the pharmaceutical industry and hence, are of great importance as they directly deal with the health of human beings. Improving research and development in the pharmaceutical industry, specifically in developing biologics, to cure different kinds of diseases is expected to drive the growth of the contract pharmaceutical fermentation services market. Various new forms of drugs are being developed from active pharmaceutical ingredients, which are further derived by fermentation for the treatment of diseases such as cancer, diabetes, myocardial infraction, anaemia and haemophilia. Thus, the increasing prevalence of diseases such as rheumatoid arthritis, cancer and diabetes drives the contract pharmaceutical fermentation services market. An expert contract pharmaceutical fermentation services provider can elevate the quality, speed, affordability and scalability of a pharmaceutical company’s programme, which is the prime factor that drives the growth of the contract pharmaceutical fermentation services market. Apart from drugs, fermentation is also used for the development of drug delivery vehicles, diagnostic kits, and medical devices driving the growth of contract pharmaceutical fermentation services market. Dynamic usage of fermentation technique in developing different pharmaceuticals fuelling the growth of contract pharmaceutical fermentation services market. Whereas, complexity of carrying out the fermentation procedure is high and to analyse large scale fermentation process may hamper the growth of contract pharmaceutical fermentation services market.

Contract Pharmaceutical Fermentation Services Market: Segmentation

Global contract pharmaceutical fermentation services market has been segmented on the basis of type of fermentation process, application and region.

Based on fermentation type, the contract pharmaceutical fermentation services market has been segmented as:

  • Solid state fermentation
  • Submerged fermentation
  • Anaerobic fermentation
  • Aerobic fermentation
  • Immobilized fermentation

Based on application, the contract pharmaceutical fermentation services market has been segmented as:

  • Metabolic production
  • Antibiotics
  • Enzymes

Contract Pharmaceutical Fermentation Services Market: Overview

With innovative use of the fermentation process across the pharmaceutical industry, the contract pharmaceutical fermentation services market is expected to witness rapid growth over the forecast period. The extensive research towards the curative treatment of cancer and other incurable diseases with the help of biological products is expected to further propel the growth of the contract pharmaceutical fermentation services market. By fermentation type, the contract pharmaceutical fermentation services market is expected to be dominated by the anaerobic fermentation involving micro-organisms segment. By application type, the antibiotics segment is expected to dominate the contract pharmaceutical fermentation services market.

Contract Pharmaceutical Fermentation Services Market: Regional Outlook

North America is expected to be the most lucrative contract pharmaceutical fermentation services market globally. Numerous pharmaceutical companies with R&D bases in North America are contributing to the enhanced demand for contract pharmaceutical fermentation services in the region. Europe is expected to be the second most lucrative region in the global contract pharmaceutical fermentation services market. Latin America and Asia-Pacific are emerging markets in contract pharmaceutical fermentation services and the Middle East and Africa region is pegged to be the least lucrative contract pharmaceutical fermentation services market.

Contract Pharmaceutical Fermentation Services Market: Market Participants

Examples of some of the market participants in the global contract pharmaceutical fermentation services market identified across the value chain include Aumgene Biosciences, Wisconsin BioProducts, EKF Diagnostics – Stanbio, BioVectra, Apotex Fermentation Inc, Capua Bioservices, AbbVie, Sandoz, Boehringer Ingelheim International GmbH, Biocon and others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes,

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
  • Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
  • Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, Rest Of MEA)

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Benefits of Becoming a Fact.MR Client

  • Access to our global market coverage
  • Periodic updates on your sector
  • Exclusive discounts and offers
  • Greater flexibility for customization
  • Quick-research assistance for ad-hoc needs
  • Access to credible insights Fact.MR analyst interactions
  • Access to Fact.MR tools and research to fuel strategy development